Catheter Precision receives $250K 8% note from CEO entity due Aug 30, 2024

Catheter Precision, Inc.

Entity controlled by CEO David A. Jenkins loans $250K at 8% interest, maturing August 30, 2024.
Note adds to $500K loan in May 2024 and $150K loan in June 2024 from same source.
Proceeds from S-1 securities sale expected to repay the note.
Jenkins and affiliates hold >10% common stock, convertible preferred, stock options, and 11.77% royalty on LockeT sales.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.